These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9388060

  • 1. Gonadoblastoma: immunohistochemical localization of Müllerian-inhibiting substance, inhibin, WT-1, and p53.
    Hussong J, Crussi FG, Chou PM.
    Mod Pathol; 1997 Nov; 10(11):1101-5. PubMed ID: 9388060
    [Abstract] [Full Text] [Related]

  • 2. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
    Zhao C, Bratthauer GL, Barner R, Vang R.
    Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different patterns of anti-Müllerian hormone expression, as related to DMRT1, SF-1, WT1, GATA-4, Wnt-4, and Lhx9 expression, in the chick differentiating gonads.
    Oréal E, Mazaud S, Picard JY, Magre S, Carré-Eusèbe D.
    Dev Dyn; 2002 Nov; 225(3):221-32. PubMed ID: 12412004
    [Abstract] [Full Text] [Related]

  • 6. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development.
    de Santa Barbara P, Moniot B, Poulat F, Berta P.
    Dev Dyn; 2000 Mar; 217(3):293-8. PubMed ID: 10741423
    [Abstract] [Full Text] [Related]

  • 7. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
    Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, Duvillard P, Chemes H, Bidart JM.
    Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R.
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [Abstract] [Full Text] [Related]

  • 10. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH.
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [Abstract] [Full Text] [Related]

  • 11. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.
    Hossain A, Saunders GF.
    Biol Reprod; 2003 Dec; 69(6):1808-14. PubMed ID: 12855602
    [Abstract] [Full Text] [Related]

  • 12. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.
    Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE.
    Mod Pathol; 1998 Jul; 11(7):656-64. PubMed ID: 9688187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT, MacLaughlin DT, Maheswaran S, Teixeira J, Fuller AF, Shah PC, Kehas DJ, Kenneally MK, Dombkowski DM, Ha TU, Preffer FI, Donahoe PK.
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP, Stoler MH.
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.